Syndicate

Latest KFF Health News Stories

KFF Health News' 'What the Health?': Biden Wins Early Court Test for Medicare Drug Negotiations

Podcast

A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration’s Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

For the Love of Health Care and Health Policy

KFF Health News Original

KFF Health News shares the crème de la crème of reader-submitted health policy valentines. Two of our favorites melted our hearts and inspired original illustrations.

States Target Health Insurers’ ‘Prior Authorization’ Red Tape

KFF Health News Original

Doctors, patients, and hospitals have railed for years about the prior authorization processes that health insurers use to decide whether they’ll pay for patients’ drugs or medical procedures. The Biden administration announced a crackdown in January, but some state lawmakers are looking to go further.

Do We Simply Not Care About Old People?

KFF Health News Original

Recently, thousands of older Americans have been dying weekly of covid. But most Americans aren’t wearing masks in public, a move that could prevent infections. Many at-risk seniors aren’t getting antiviral therapies, and older adults in nursing homes aren’t getting vaccines. Why?

KFF Health News' 'What the Health?': To End School Shootings, Activists Consider a New Culprit: Parents

Podcast

For the first time, a jury has convicted a parent of a school shooter of charges related to the child’s crime, finding a mother in Michigan guilty of involuntary manslaughter and possibly opening a new legal avenue for gun control advocates. Meanwhile, as the Supreme Court prepares to hear a case challenging the FDA’s approval of the abortion drug mifepristone, a medical publisher has retracted some of the journal studies that lower-court judges relied on in their decisions. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of KFF Health News join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.